Yes — Publications

Yes

Publications

39

Total Publications

8

Abstract/Manuscript

27

Oral Presentation

4

Poster Presentation

2025 · Abstract/Manuscript · GSK

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence

2025 · Poster Presentation · Yes · Methods/Pharmacoepi

Assessing artificial censoring weights for clone censor weighting studies: A simulation-based approach

2024 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Propensity Score Methods for Confounding Control in Observational Studies of Therapeutics for COVID-19 Infection

2024 · Oral Presentation · Yes · Methods/Pharmacoepi

Making the Case for Negative Control Outcome Studies in a Real-World Evidence Setting

2024 · Oral Presentation · Yes · Methods/Pharmacoepi

Seeing Eye to Eye: Enhancing Inter-Team Communication for Reproducible Real-World Evidence

2024 · Oral Presentation · Yes · Methods/Pharmacoepi

Comparing causal estimands from a sequential nested trial emulation with a treatment decision design to a conventional single point randomized trial: A simulation study

2024 · Poster Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

Addressing RWE Challenges in Real-Time: The 'Clean Room Committee' Approach

2024 · Poster Presentation · Yes · Methods/Pharmacoepi

Utilizing Patient Electronic Medical Records to Transform Clinical Trials

2024 · Poster Presentation · Yes · Methods/Pharmacoepi

Prediction in claims databases for epidemiological research

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative review

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Controlling for Differential Regression-To-The-Mean via Propensity Scores: A Simulation Study

2023 · Oral Presentation · Yes · Methods/Pharmacoepi

Methods and New Approaches in Pragmatic Trials

2023 · Oral Presentation · Yes · Methods/Pharmacoepi

Characterizing the Distribution of Multiple Negative Control Outcome Risk Differences

2023 · Oral Presentation · Yes · Methods/Pharmacoepi

Orthogonalized Regression for Causal Inference: A Pharmacoepidemiologist's Dream?

2023 · Oral Presentation · Yes · Methods/Pharmacoepi

An Analytic Method to Weight Longitudinal Treatment Patterns for Visualization with Sankey Diagrams

2022 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Lipid Testing Trends Before and After Hospitalization for Myocardial Infarction Among Adults in the United States, 2008-2019

2022 · Abstract/Manuscript · University of North Carolina at Chapel Hill

DAG With Omitted Objects Displayed (DAGWOOD): a framework for revealing causal assumptions in DAGs

2022 · Oral Presentation · Yes · Methods/Pharmacoepi

In-Hospital Treatment Patterns Among Patients Hospitalized with COVID-19 in the United States

2022 · Oral Presentation · Yes · Methods/Pharmacoepi

Discharged Where? The Importance of Understanding Discharge Dispositions When Estimating In-Hospital Mortality

2022 · Oral Presentation · Amgen Inc. · Methods/Pharmacoepi

Fracture Risk Estimation in Post-menopausal Women: A Comparison of Machine Learning Methods and Software Systems

2022 · Oral Presentation · Yes · Methods/Pharmacoepi

Risk Factors for Mortality and Intensive Care Requirements Among Pediatric Patients Hospitalized with COVID-19 in the United States

2022 · Oral Presentation · Yes · Methods/Pharmacoepi

The Effect of Remdesivir for The Treatment of COVID-19 on Mortality Among Hospitalized Patients

2022 · Oral Presentation · Yes · Methods/Pharmacoepi

Negative Control Outcomes to Assess the Comparability of Biologics versus Small-molecule Therapeutics for Osteoporosis: Considerations for Differential Non-adherence

2022 · Oral Presentation · Yes · Methods/Pharmacoepi

The impact of parametric assumptions on the bias-variance tradeoff for causal analysis of time-to-event outcomes

2022 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

Fusion Designs for Indirect Treatment Effects

2022 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

On Teaching Advanced Epidemiologic Methods

2022 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

Bridged treatment comparisons: an illustrative application in HIV treatment

2022 · Oral Presentation · Yes · Methods/Pharmacoepi

Disparities in Prevalence of Urinary Incontinence among a Nationally Representative Sample of Men, 2005-2016: Findings from the Urologic Diseases in America Project

2021 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies

2021 · Oral Presentation · University of California Los Angeles · Methods/Pharmacoepi

Fusion designs and estimators for treatment effects

2020 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Who are we missing? Underrepresentation of data sources used for pharmacoepidemiology research in the United States

2020 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

Estimating the Effect of Depression on HIV Transmission Risk Behaviors Among People Who Inject Drugs in Vietnam: A Causal Approach

2020 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

G-computation for policy-relevant effects of interventions on time-to-event outcomes

2019 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

Using Instrumental Variables to Address Bias from Unobserved Confounders

2019 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

Commentary: Compositional data call for complex interventions

2019 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

Using Bounds to Compare the Strength of Exchangeability Assumptions for Internal and External Validity

2019 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

Informative censoring by health plan disenrollment among commercially insured adults

2019 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

Nonparametric Bounds for the Risk Function

2018 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

A Practical Example Demonstrating the Utility of Single-world Intervention Graphs

Macro photograph of translucent oil bubbles on a vibrant orange and red gradient background, evoking scientific and biological imagery.

Contact us

By submitting this form, you consent to your information used by Headwater Science for the purpose of contacting you to better understand your potential interest in Headwater Science and/or its services. For more information, see our privacy policy.